remyelin
demyelin
central
nervou
system
cn
axon
consid
potenti
treatment
multipl
sclerosi
achiev
experiment
model
demyelin
transplant
promyelin
cell
howev
experi
undertaken
address
need
tissuetyp
match
order
achiev
graftmedi
remyelin
sinc
perform
condit
chanc
graft
reject
minim
articl
focus
factor
determin
surviv
allogen
oligodendrocyt
lineag
cell
contribut
remyelin
demyelin
cn
lesion
immun
statu
cn
well
suitabl
differ
model
demyelin
graft
reject
studi
discuss
way
enhanc
allogen
oligodendrocytemedi
remyelin
present
final
effect
glial
graft
reject
host
remyelin
describ
highlight
potenti
benefit
acut
cn
inflammatori
respons
myelin
repair
number
human
condit
character
loss
central
nervou
system
cn
myelin
commonest
multipl
sclerosi
ms
diseas
immun
attack
target
myelin
sheath
cell
produc
oligodendrocyt
result
focal
area
demyelin
plaqu
scatter
throughout
white
matter
cn
lassmann
although
remyelin
demyelin
axon
occur
process
becom
defect
diseas
progress
result
remyelin
failur
lassmann
demyelin
axon
affect
axon
conduct
associ
axon
loss
result
progress
neurolog
handicap
weinshenk
associ
remyelin
failur
diseas
progress
enhanc
remyelin
becom
therapeut
goal
ms
research
principl
remyelin
axon
could
achiev
enhanc
endogen
remyelin
transplant
exogen
myelinform
cell
attempt
enhanc
endogen
remyelin
infus
trophic
factor
cytokin
render
variabl
result
could
due
fact
trophic
factor
pleiotroph
effect
brain
review
imitola
et
al
anim
model
use
repres
exampl
remyelin
failur
transplantmedi
remyelin
howev
achiev
varieti
anim
model
demyelin
shown
result
function
recoveri
review
baronvan
evercooren
blakemor
articl
review
current
understand
glial
cell
transplant
demyelin
diseas
address
base
limit
amount
specif
inform
avail
extent
tissu
match
essenti
requir
success
cell
therapi
remyelin
demyelin
lesion
achiev
transplant
sever
differ
cell
prepar
includ
cell
deriv
immatur
adult
cn
schwann
cell
olfactori
ensheath
cell
cell
nonneur
tissu
even
though
abil
cell
remyelin
demyelin
cn
axon
establish
anim
model
demyelin
suitabl
cell
type
potenti
clinic
therapi
must
question
schwann
cell
remyelin
certain
type
demyelin
lesion
effici
process
lead
improv
axon
conduct
honmou
et
al
cell
unabl
coexist
astrocyt
review
baronvan
evercooren
blakemor
impli
cell
would
suitabl
candid
transplant
ms
lesion
sinc
character
astrocyt
hypertrophi
olfactori
ensheath
cell
integr
astrocyt
environ
vitro
better
schwann
cell
lakato
et
al
gener
less
astrocyt
respons
upon
transplant
normal
white
matter
lakato
et
al
suggest
would
better
candid
transplant
astrocyt
contain
demyelin
area
cn
howev
exact
behaviour
olfactori
ensheath
cell
within
environ
consist
demyelin
axon
accompani
astrocyt
still
remain
establish
franklin
transplant
pluripot
cell
outsid
cn
attempt
order
achiev
remyelin
sever
report
indic
bone
marrow
could
use
achiev
remyelin
demyelin
cn
axon
review
baronvan
evercooren
blakemor
also
suggest
umbil
cord
bloodderiv
stem
cell
differenti
oligodendrocyt
vitro
buzanska
et
al
howev
differenti
observ
upon
transplant
newborn
rodent
brain
zigova
et
al
abil
haematopoiet
stem
cell
gener
neural
cell
question
wager
et
al
thu
use
cell
potenti
remyelin
therapi
must
consid
caution
oligodendrocyt
lineag
cell
success
use
achiev
remyelin
demyelin
cn
lesion
review
baronvan
evercooren
blakemor
studi
show
myelin
potenti
cell
prepar
follow
engraft
depend
degre
enrich
immatur
cell
therefor
foetal
cell
effect
myelin
format
neonat
adult
one
engraft
neonat
cn
oligodendrocyt
precursor
effici
preoligodendrocyt
matur
oligodendrocyt
howev
also
appear
commit
multipot
neural
precursor
oligodendrocyt
lineag
prior
transplant
requir
achiev
signific
remyelin
follow
engraft
glialfre
area
acut
demyelin
smith
blakemor
furthermor
cell
gener
oligodendrocyt
progenitor
cell
opc
transplant
normal
adult
tissu
sinc
integr
cell
inhibit
presenc
endogen
opc
hink
et
al
sinc
abil
oligodendrocyt
precursor
cell
perform
remyelin
astrocyt
environ
well
establish
review
baronvan
evercooren
blakemor
cell
repres
best
candid
transplantmedi
remyelin
clinic
best
sourc
human
opc
like
embryon
foetal
tissu
review
franklin
achiev
exact
haplotyp
match
donor
host
extrem
difficult
due
polymorph
human
gene
drukker
benvenisti
import
evalu
extent
allogen
opc
requir
tissu
match
order
achiev
remyelin
demyelin
cn
lesion
follow
section
review
data
avail
regul
adapt
immun
within
cn
first
major
histocompat
mhc
express
cn
glia
repres
main
determin
graft
reject
analysi
becom
appar
glial
cell
engraft
treatment
demyelin
cn
disord
may
repres
doubl
privileg
scenario
sinc
site
engraft
character
exquisit
regul
immun
respons
also
tissu
engraft
may
low
immunogen
sinc
character
low
constitut
mhc
express
consid
immun
respons
graft
place
brain
spinal
cord
one
take
account
cn
consid
one
immun
privileg
site
bodi
other
eye
anterior
chamber
subretin
space
vitreou
caviti
cornea
test
placenta
barker
billingham
immun
respons
site
differ
occur
part
bodi
immun
privileg
cn
histor
perspect
notion
immun
privileg
cn
rais
studi
surviv
transplant
tissu
tumour
cell
brain
conduct
first
half
twentieth
centuri
review
barker
billingham
experi
show
allogen
cell
surviv
longer
brain
parenchyma
extracerebr
site
time
interpret
experi
brain
isol
immun
system
first
absenc
classic
defin
lymphat
within
brain
secondli
presenc
bloodbrain
barrier
bbb
consist
endotheli
cell
seal
togeth
tight
junction
lead
idea
affer
effer
arm
immun
respons
intracerebr
antigen
absent
suggest
brain
tissu
uncongeni
environ
lymphoid
cell
murphi
sturm
howev
author
made
import
observ
region
differ
exist
within
brain
microenviron
transplant
cellular
antigen
surviv
longer
place
cerebr
cortex
prolong
surviv
ventricl
reject
observ
chang
view
immun
privileg
cn
indic
absolut
experi
medawar
suggest
bbb
suffici
prevent
entri
immun
cell
cn
observ
skin
allograft
place
brain
fail
induc
usual
reject
respons
observ
peripher
site
graft
would
undergo
reject
recipi
reject
previou
skin
graft
interpret
brain
graft
could
reject
recipi
contain
sourc
circul
lymphocyt
activ
immun
recipi
peripher
skin
graft
place
antigen
brain
fail
stimul
naiv
lymphocyt
experi
scheinberg
et
al
show
allogen
skin
graft
place
brain
acceler
reject
compar
graft
peripheri
indic
presenc
antigen
brain
could
also
stimul
affer
arm
immun
respons
concept
immun
privileg
nowaday
redefin
away
belief
ignor
cn
antigen
immun
system
toward
understand
mainten
immun
privileg
statu
cn
activ
process
immun
respons
antigen
brain
specif
regul
affer
lymphat
drainag
effer
access
effector
cell
arm
immun
system
oper
within
cn
function
differ
peripher
tissu
harlingberg
et
al
raju
grogan
defin
paradox
immun
privileg
state
immun
system
awar
respond
antigen
foreign
graft
unabl
mount
destruct
immun
attack
review
streilein
taylor
b
affer
immun
system
cn
theori
antigen
present
within
brain
could
reach
immun
system
two
mean
first
solubl
antigen
may
exit
brain
drain
cerebrospin
fluid
csf
interstiti
fluid
isf
second
profession
antigen
present
cell
apc
could
carri
antigen
brain
region
lymph
node
antigen
present
initi
immun
respons
would
occur
drainag
fluid
solubl
antigen
rout
solubl
brain
antigen
drainag
clearli
establish
review
harlingberg
et
al
long
time
recogn
substanc
introduc
cn
efflux
subarachnoid
space
blood
cervic
lymph
review
howev
laboratori
anim
drainag
lymph
appear
signific
immunolog
review
great
contribut
understand
cn
drainag
provid
develop
rodent
model
normal
bbb
permeabl
helen
cserr
paul
knopf
laboratori
review
harlingberg
et
al
model
antigen
microinfus
csf
brain
tissu
cannula
implant
one
week
one
week
delay
ensur
restor
normal
bbb
function
model
avoid
disadvantag
studi
involv
disrupt
bbb
acut
insert
needl
cannula
also
inject
larg
volum
antigen
could
immedi
efflux
blood
lymph
use
approach
becom
clear
subarachnoid
space
isf
csf
either
drain
dural
sinou
blood
via
arachnoid
villi
escap
extracrani
tissu
space
via
prolong
subarachnoid
space
along
certain
cranial
nerv
kida
et
al
includ
olfactori
optic
trigemin
acoust
nerv
review
primari
outflow
pathway
common
laboratori
anim
along
arachnoid
sheath
olfactori
nerv
cribriform
plate
nasal
submucosa
review
harlingberg
et
al
also
good
evid
csf
transport
human
occur
cribriform
plate
nasal
submucosa
weller
et
al
lowhagen
et
al
caversaccio
et
al
outflow
spinal
subarachnoid
space
also
appear
involv
drainag
venou
blood
via
arachnoid
granul
tissu
space
outsid
spinal
column
passag
along
spinal
nerv
root
ganglia
kida
et
al
substanc
drain
cranial
subarachnoid
space
via
olfactori
pathway
clear
nasal
submucosa
passag
termin
lymphat
blood
capillari
thu
protein
larg
molecular
weight
substanc
preferenti
enter
lymphat
recov
high
concentr
rel
blood
plasma
deep
cervic
lymph
node
jugular
lymph
trunk
bradburi
westrop
review
cserr
knopf
smaller
molecular
weight
substanc
da
less
howev
appear
low
concentr
lymph
lost
blood
due
greater
abil
penetr
permeabl
vascular
endothelium
nasal
submucosa
lymph
node
bradburi
westrop
ii
immun
respons
result
drainag
solubl
brain
antigen
administr
antigen
brain
well
anoth
immun
privileg
siteth
anterior
chamber
eye
elicit
stereotyp
immun
respons
streilein
taylor
therefor
site
delay
type
hypersensit
dth
respons
suppress
streilein
harlingberg
et
al
humor
immun
stimul
harlingberg
et
al
wilbank
streilein
moreov
antibodi
respons
inflammatori
sinc
concentr
complement
compon
low
normal
rat
csf
antibodi
isotyp
mice
immun
anterior
chamber
eye
solubl
protein
found
bias
complement
nonfix
igg
subclass
wilbank
streilein
develop
cytotox
lymphocyt
ctl
respons
infus
brain
antigen
appear
impair
well
gordon
et
al
assess
ctl
develop
cervic
lymph
node
spleen
mice
respons
microinfus
mastocytoma
cell
caudat
nucleu
reveal
even
though
antigenspecif
prectl
commit
lymph
node
occur
direct
ctl
activ
absent
failur
progress
direct
ctl
consist
humor
bias
respons
antigen
introduc
brain
iii
cnsantigen
present
cell
although
experi
helen
cserr
laboratori
establish
solubl
antigen
cn
drain
cervic
lymph
node
rodent
yet
clear
whether
cn
contain
cell
capabl
captur
antigen
carri
cervic
lymph
node
could
prime
naiv
cell
sever
cell
type
suggest
function
cn
apc
includ
dendrit
cell
dc
microglia
cn
macrophag
astrocyt
dendrit
cell
appear
cn
dc
restrict
certain
compart
thu
dc
absent
normal
rodent
brain
parenchyma
karman
et
al
present
leptomening
vass
et
al
matyszak
perri
mcmenamin
choroid
plexu
matyszak
perri
human
csf
also
contain
dc
number
increas
ms
pashenkov
et
al
pashenkov
et
al
consist
studi
show
lack
immun
reactiv
pathogen
introduc
brain
parenchyma
vigor
respons
pathogen
csf
poltorak
freed
even
though
normal
brain
parenchyma
contain
dc
presenc
induc
patholog
situat
toxoplasma
gondii
infect
fischer
et
al
experiment
allerg
encephalomyel
eae
fischer
reichmann
traumat
brain
injuri
serafini
et
al
howev
complet
clear
whether
appear
cell
dc
featur
parenchyma
cn
patholog
due
differenti
endogen
dc
precursor
recruit
peripheri
work
fischer
reichmann
suggest
microglia
may
dc
precursor
sinc
upon
stimul
vitro
granulocytemonocyt
coloni
stimul
factor
gmcsf
start
express
pan
dc
surfac
marker
also
possibl
bloodborn
mening
dc
recruit
via
perivascular
space
fischer
reichmann
exampl
eae
dc
invad
cn
precursor
togeth
bloodderiv
cell
serafini
et
al
suter
et
al
appear
dc
migrat
cn
drain
lymph
node
sinc
inject
intracerebr
accumul
deep
cervic
lymph
node
karman
et
al
import
question
need
clarif
function
dc
appear
cn
inflamm
cnsdc
isol
toxoplasma
gondii
infect
mous
brain
function
potent
apc
fischer
et
al
isol
eae
mice
unabl
prime
naiv
cell
moreov
inhibit
cell
prime
bone
marrowderiv
dc
suter
et
al
therefor
appear
certain
dc
subset
major
role
maintain
peripher
toler
cn
antigen
surpris
sinc
dc
shown
particip
mainten
selftoler
constant
present
selfantigen
heath
carbon
steinman
nussenzweig
therefor
studi
need
conduct
clarifi
role
dc
cn
resid
cn
apc
besid
dc
cell
suggest
function
apc
cn
microglia
perivascular
macrophag
primari
candid
especi
latter
sinc
role
indispens
develop
eae
hickey
kimura
perivascular
cell
enter
cn
continu
hickey
kimura
hickey
et
al
take
resid
beyond
endotheli
basement
membran
lassmann
et
al
hickey
et
al
ingest
accumul
materi
via
scaveng
receptor
mediat
endocytosi
kida
et
al
mato
et
al
becom
progress
granular
result
transplant
studi
evid
perivascular
cell
actual
leav
cn
return
immun
system
tissu
presum
carri
materi
found
cn
broadwel
et
al
could
therefor
way
prime
immun
system
graft
molecul
lead
graft
reject
howev
clear
whether
microgli
cell
andor
macrophag
migrat
cn
signific
number
present
antigen
secondari
lymphoid
organ
also
microgli
cell
significantli
less
effici
prime
naiv
cell
profession
apc
dc
aloisi
et
al
howev
possibl
cell
develop
dc
certain
proinflammatori
condit
exampl
mention
activ
microglia
potenti
develop
dc
vitro
respons
gmcsf
major
cytokin
stimul
dc
develop
bone
marrow
precursor
monocyt
fischer
et
al
hamilton
et
al
astrocyt
anoth
cell
type
whose
role
stimul
cell
suggest
fontana
et
al
cell
probabl
major
direct
role
antigen
present
cn
karman
et
al
upregul
mhc
ii
molecul
interferong
ifn
seen
vitro
cornet
et
al
hard
reproduc
vivo
induc
primari
cell
respons
sinc
migrat
cn
also
clear
whether
cell
role
reactiv
cell
enter
cn
review
karman
et
al
c
effer
arm
immun
system
cn
immun
cell
entri
long
time
consid
bbb
prevent
entri
leukocyt
cn
howev
becom
evid
wide
varieti
white
blood
cell
traffic
cn
leukocyt
cell
type
traffic
healthi
cn
part
normal
physiolog
entri
cell
type
sign
patholog
sinc
appear
search
specif
antigen
respons
tissu
damag
hickey
cell
nowaday
evid
cell
traffick
part
normal
surveil
cn
review
hickey
gener
consid
activ
cell
requir
entri
cn
thu
rat
cell
specif
ovalbumin
found
neural
parenchyma
cell
infus
anim
activ
lymphoblast
state
review
hickey
passiv
eae
induc
cn
antigen
specif
cell
stimul
prior
administr
holda
et
al
panitch
review
hickey
entri
activ
cell
transfer
independ
mhc
compat
host
specif
cell
phenotyp
presenc
cn
antigen
cell
specif
therefor
traffick
activ
cell
cn
thought
nonspecif
phenomenon
howev
recent
number
studi
seabrook
et
al
seabrook
et
al
brought
activ
requir
cell
entri
cn
question
sinc
report
rest
lymphocyt
enter
csf
probabl
cn
normal
anim
also
brabb
et
al
detect
naiv
myelin
basic
protein
mbp
specif
cell
nervou
system
cn
autoantigenspecif
cell
receptor
tcr
transgen
mice
cell
appear
render
unrespons
cn
environ
even
though
cell
entri
cn
occur
constantli
concentr
cn
much
lower
organ
without
welldevelop
bloodtissu
barrier
yeager
et
al
within
cn
appear
distinct
differ
number
cell
found
differ
level
neural
parenchyma
highest
number
cell
within
lumbar
spinal
cord
hickey
moreov
abil
cell
gain
entri
differ
level
cn
seem
relat
vulner
level
inflamm
associ
eae
berger
et
al
cell
entri
appear
nonspecif
phenomenon
retent
cell
cn
specif
cell
find
antigen
context
mhc
molecul
cn
retain
review
hickey
complet
clear
happen
cell
enter
cn
mani
die
apoptosi
schmi
et
al
bauer
et
al
especi
case
cell
enter
parenchyma
bauer
et
al
place
csf
disappear
rapidli
happen
probabl
cell
migrat
cell
death
hickey
unexpect
role
cell
one
may
import
consid
consequ
cn
graft
reject
abil
foster
cn
repair
review
hohlfeld
et
al
schwartz
cohen
bieber
et
al
shown
neuroprotect
effect
cell
depend
cell
subtyp
activ
state
cell
protect
cell
wolf
et
al
ii
natur
killer
cell
much
known
entri
function
fate
natur
killer
nk
cell
healthi
cn
inflamm
develop
known
cell
repres
total
infiltr
eae
zhang
et
al
matsumoto
et
al
studi
howev
suggest
cell
may
play
moder
suppress
role
sinc
deplet
render
acut
eae
sever
nk
cell
becom
detect
spinal
cord
day
first
cell
arriv
rat
eae
presenc
detect
cell
enter
cn
locat
antigen
cn
destin
develop
inflamm
hickey
healthi
cn
igg
ratio
serum
csf
approxim
yet
diseas
high
concentr
igg
present
csf
indic
plasma
cell
must
way
enter
cn
becom
establish
system
use
cserr
laboratori
mention
found
antigen
anim
sensit
introduc
brain
plasma
cell
b
cell
specif
antigen
appear
extens
inflamm
occur
harlingberg
et
al
antigen
anim
sensit
introduc
minim
chang
observ
therefor
appear
like
case
cell
entri
b
cell
specif
retent
cn
iv
monocytemacrophag
famili
member
group
cell
includ
microgli
cell
sedgwick
hickey
perivascular
microglia
macrophag
cell
sedgwick
hickey
mening
macrophag
choroid
plexu
macrophag
matyszak
et
al
epiplexu
cell
standard
phagocyt
macrophag
gitter
cell
area
parenchym
damag
parenchym
microglia
take
resid
cn
foetal
life
perri
monocyt
element
turn
throughout
life
hickey
et
al
perri
sedgwick
hickey
mening
macrophag
replac
quickli
continu
bone
marrow
perivascular
cell
choroid
plexu
macrophag
also
turn
less
rapidli
hickey
et
al
appear
activ
monocyt
famili
import
enhanc
transendotheli
migrat
essenti
persidski
et
al
environ
immun
privileg
site
brain
anterior
chamber
eye
antiinflammatori
establish
aqueou
humour
eye
suppress
cell
prolifer
modul
activ
macrophag
review
streilein
taylor
also
exposur
periton
exud
cell
aqueou
humour
eye
csf
vitro
confer
abil
cell
present
antigen
deviant
manner
known
lead
induct
toler
wilbank
streilein
capac
induct
deviant
immun
mediat
least
part
transform
growth
factor
tgf
b
gordon
et
al
show
normal
rat
csf
suppress
vitro
develop
mastocytomaspecif
ctl
activ
restimul
splenocyt
balbc
mice
strain
unabl
reject
tumour
brain
suppress
depend
tgfb
revers
suppress
achiev
specif
neutral
antibodi
cn
molecul
capabl
modul
immun
activ
includ
interleukin
neuropeptid
substanc
p
sp
vasointestin
peptid
vip
review
benvenist
belling
et
al
therefor
factor
present
within
cn
environ
also
contribut
suppress
destruct
immun
respons
studi
undertaken
far
investig
surviv
allograft
brain
focus
surviv
neuron
mean
replac
lost
neurodegen
diseas
prolong
surviv
brain
compar
site
frequent
observ
number
studi
report
reject
mason
et
al
nichola
et
al
date
et
al
poltorak
freed
reject
appear
unpredict
variabl
consider
delay
incomplet
head
griffin
mason
et
al
therefor
experi
undertaken
order
investig
mechan
reject
factor
influenc
reject
possibl
way
overcom
bartlett
et
al
investig
whether
remov
mhc
iexpress
cell
could
enhanc
surviv
neural
precursor
brain
first
determin
neural
precursor
isol
brain
mice
express
mhc
class
molecul
compar
surviv
neuroepitheli
whole
cell
prepar
surviv
prepar
mhc
neg
cell
isol
neuroepithelium
wherea
whole
epithelium
underw
reject
allogen
host
mhc
neg
prepar
show
good
surviv
even
six
month
posttransplant
surviv
neural
allograft
appear
influenc
site
implant
sloan
et
al
compar
surviv
solid
tissu
cortex
place
either
third
ventricl
later
ventricl
caudat
putamen
parenchyma
graft
place
parenchyma
show
much
better
surviv
place
ventricl
also
surviv
depend
donorhost
strain
combin
exampl
wherea
pvg
graft
ao
rat
reject
accompani
heavi
immun
infiltr
ao
graft
pvg
rat
show
littl
cell
infiltr
gener
good
surviv
anoth
studi
also
show
donorhost
strain
combin
influenc
surviv
neural
allogen
tissu
isono
et
al
show
donorhost
strain
combin
certain
graft
surviv
even
host
sensit
donor
skin
twice
exampl
lewi
l
graft
surviv
well
brown
norway
n
pvg
c
ao
u
pvg
u
even
sensit
wherea
brown
norway
graft
therefor
author
impli
haplotyp
graft
could
influenc
reject
also
notic
suscept
host
strain
eae
appear
relat
suscept
reject
thu
eae
suscept
strain
lewi
l
l
show
vigor
reject
respons
eae
nonsuscept
strain
observ
suggest
surviv
neural
graft
influenc
haplotyp
donor
host
mhc
allel
suscept
autoimmun
diseas
anoth
factor
determin
graft
surviv
appear
immunorespons
gene
mhc
link
gene
control
alloimmun
respons
class
antigen
rat
make
strain
low
respond
mhc
haplotyp
high
respond
other
studi
address
surviv
allogen
neural
tissu
studi
specif
studi
surviv
allogen
oligodendrocyt
studi
li
duncan
examin
respons
myelin
defici
md
rat
allogen
glial
cell
studi
cell
prepar
aci
spinal
cord
day
old
rat
transplant
spinal
cord
day
old
md
pup
allogen
graft
reject
two
week
posttransplant
experi
cell
microgli
cell
recipi
neonat
pup
extens
studi
allogen
oligodendrocyt
surviv
normal
adult
anim
perform
number
model
exist
possibl
studi
myelin
potenti
transplant
cell
choos
model
suitabl
studi
immunogen
myelinogen
cell
govern
number
constraint
section
analys
model
use
demonstr
transplantmedi
myelin
comment
suitabl
investig
surviv
allogen
myelinogen
cell
basic
principl
underli
model
axon
avail
progeni
transplant
cell
myelin
develop
nervou
system
mani
studi
use
develop
nervou
system
transplant
site
assess
myelingener
potenti
introduc
cell
cell
inject
cn
embryo
newborn
rat
mous
pup
recipi
repres
highli
permiss
environ
myelin
transplant
cell
respond
development
cue
thu
ideal
assess
myelin
potenti
howev
toler
induct
antigen
introduc
earli
embryon
neonat
life
recipi
unsuit
evalu
immun
respons
graft
cell
myelin
mutant
compris
group
anim
myelin
sheath
product
perturb
due
defect
myelin
protein
relat
gene
classifi
differ
group
accord
myelin
protein
gene
affect
mbp
mutant
shiver
mous
long
evan
rat
lack
mbp
lead
abnorm
myelin
sheath
format
howev
oligodendrocyt
process
associ
axon
form
thin
uncompact
myelin
week
age
could
interfer
transplantmedi
remyelin
gout
et
al
util
model
lie
fact
easi
identifi
mbp
posit
myelin
sheath
tissu
normal
anim
transplant
mutant
cn
howev
achiev
signific
myelin
matur
anim
demyelin
lesion
must
induc
review
baronvan
evercooren
blakemor
ii
phospholipid
protein
plp
mutant
includ
myelin
defici
md
rat
shake
pup
jimpi
jp
mous
anim
mutat
duplic
plp
gene
result
death
oligodendrocyt
begin
myelin
axon
review
ikenaka
kagawa
md
rat
boison
stoffel
jp
mous
farka
bargeton
et
al
well
canin
shake
pup
duncan
et
al
small
number
oligodendrocyt
surviv
synthes
small
amount
myelin
theoret
sever
myelin
defici
allow
signific
transplantmedi
myelin
howev
disadvantag
use
anim
short
life
span
day
make
evalu
long
term
consequ
remyelin
imposs
even
though
shake
pup
slightli
longer
life
span
nurs
anim
time
consum
expens
iii
transgen
anim
overexpress
plp
gene
repres
anoth
model
studi
transplant
promyelin
cell
espinosa
de
lo
montero
et
al
homozyg
mice
sever
hypomyelin
short
life
span
similar
jimpi
mice
heterozyg
mice
long
life
span
could
use
adult
graft
recipi
sinc
normal
myelin
follow
progress
demyelin
start
three
four
month
kagawa
et
al
iv
myelin
associ
glycoproteinfyn
nonreceptor
tyrosin
kinas
src
famili
knockout
mice
hypomyelin
biffig
et
al
anim
normal
life
span
use
transplant
recipi
although
experi
far
undertaken
perform
postnat
anim
ader
et
al
v
anoth
myelin
mutant
anim
taiep
rat
anim
microtubular
defect
oligodendrocyt
result
disrupt
normal
myelin
process
certain
area
cn
failur
mainten
myelin
sheath
elsewher
lead
progress
demyelin
result
tissu
patholog
reminisc
chronic
area
demyelin
found
ms
duncan
et
al
recent
studi
adult
taiep
rat
demonstr
two
import
limit
achiev
remyelin
clinic
context
transplant
studi
matur
myelin
mutant
first
confirm
deplet
endogen
opc
essenti
requir
achiev
repopul
tissu
transplant
opc
foot
blakemor
secondli
studi
highlight
requir
acut
inflammatori
respons
gener
remyelin
oligodendrocyt
opc
foot
blakemor
implic
studi
opc
transplant
tissu
contain
endogen
opc
result
widespread
colon
tissu
even
opc
establish
within
area
chronic
demyelin
follow
remyelin
unless
cell
activ
eg
induct
acut
inflammatori
respons
therefor
even
though
myelin
mutant
repres
use
model
studi
promyelin
potenti
transplant
cell
may
suitabl
model
undertak
reject
studi
first
disadvantag
anim
short
live
transplant
studi
perform
develop
anim
mention
lead
induct
toler
secondli
studi
reject
requir
anim
normal
immunorespons
even
though
one
studi
address
immun
statu
md
rat
found
normal
li
duncan
issu
mutanttransgen
anim
investig
thirdli
precis
studi
reject
respons
mismatch
tissu
requir
use
inbr
anim
attract
model
taiep
rat
deriv
outbr
strain
rat
spraguedawley
final
one
keep
mind
transplant
normal
myelin
cell
mutant
anim
impli
genet
mismatch
donor
host
could
stimul
immun
respons
nonmyelin
retina
also
use
model
graftmedi
myelin
howev
extent
myelin
achiev
matur
anim
limit
review
baronvan
evercooren
blakemor
focal
area
demyelin
induc
adult
anim
inject
chemic
gliotoxin
white
matter
area
specif
kill
glial
cell
without
kill
axon
review
baronvan
evercooren
blakemor
commonli
use
toxin
lysolecithin
lysophosphatidyl
cholin
ethidium
bromid
eb
lysolecithin
particular
toxic
myelin
spare
oligodendrocyt
possibl
progenitor
within
area
demyelin
ebinduc
lesion
larger
induc
lysolecithin
dna
intercal
agent
kill
astrocyt
oligodendrocyt
well
oligodendrocyt
precursor
throughout
area
demyelin
toxin
use
produc
demyelin
dorsal
funiculu
spinal
cord
caudal
cerebellar
peduncl
inject
antigalactocerebrosid
antigalc
antibodi
complement
also
use
produc
demyelin
lesion
cn
appear
larg
volum
prepar
requir
induc
signific
area
demyelin
toxininduc
lesion
adult
anim
repres
suitabl
model
studi
graft
reject
sinc
transplantmedi
remyelin
would
evalu
adult
anim
presum
normal
immun
respons
use
inbr
strain
experi
would
ensur
appropri
manipul
mhc
mismatch
sinc
eb
lysolecithininduc
lesion
repres
betterdevelop
model
antigalc
antibodi
complement
produc
lesion
eb
lesion
larger
lysolecithin
induc
one
known
toxic
oligodendrocyt
opc
use
prefer
toxininduc
model
demyelin
studi
reject
glial
graft
discuss
later
lesion
intrins
remyelin
capac
therefor
mean
distinguish
graftmedi
remyelin
undertaken
host
cell
must
employ
model
use
frequent
toxin
inject
myelin
mutant
assess
myelin
potenti
transplant
cell
character
complex
pathophysiolog
featur
widespread
dispers
lesion
fact
show
spontan
remyelin
possibl
wide
use
model
eae
model
demyelin
induc
sensit
anim
myelin
compon
inject
cn
homogen
purifi
myelin
myelin
protein
freund
adjuv
monophas
type
eae
acut
eae
passiv
transfer
eae
show
littl
demyelin
remiss
exacerb
chronicrelaps
eae
antibodydepend
eae
wide
dispers
lesion
throughout
cn
prefer
spinal
cord
studi
perform
model
report
potenti
surviv
migrat
transplant
cell
abil
improv
clinic
recoveri
tourbah
et
al
pluchino
et
al
necessari
ultim
evalu
allograft
surviv
model
autoimmun
demyelin
diseas
eae
may
inappropri
studi
whose
primari
focu
studi
immunogen
glial
cell
prepar
addit
appreci
sever
featur
ms
reflect
eae
exampl
eae
diseas
cell
appear
predomin
ms
lesion
moreov
ifng
administr
tumour
necrosi
factor
tnf
block
amelior
eae
treatment
exarceb
ms
review
lassmann
ransohoff
sinc
normal
glial
popul
cn
intrins
replac
capac
import
mean
clearli
identifi
myelin
form
transplant
cell
therefor
import
issu
must
address
carri
allograft
experi
identif
transplant
cell
manner
interfer
allograft
surviv
rais
possibl
immun
recognit
marker
use
sinc
could
complic
interpret
result
identif
transplant
myelin
cell
achiev
two
way
reliabl
marker
transplant
cell
use
demyelin
lesion
model
endogen
remyelin
suppress
graftspecif
marker
transplant
cell
label
vitro
prior
transplant
exogen
label
use
vital
dye
fast
blue
espinosa
de
lo
montero
et
al
bisbenzimidehoechst
dye
gansmul
et
al
subsequ
identif
use
fluoresc
microscopi
howev
exogen
label
well
use
mitot
sphase
marker
tritiat
thymidin
brdu
disadvantag
becom
dilut
repeat
divis
transplant
cell
addit
dye
taken
host
cell
time
transplant
iwashita
et
al
also
direct
transfer
label
host
cell
macrophag
transplant
cell
die
rather
use
exogen
label
genet
marker
use
order
avoid
problem
dilut
transfer
associ
vitro
label
marker
introduc
gene
green
fluoresc
protein
gfp
herrera
et
al
windrem
et
al
bacteri
lacz
directli
cell
tontsch
et
al
franklin
et
al
cell
deriv
transgen
anim
friedrich
lazzarini
lachapel
et
al
inher
genet
mismatch
donor
host
also
use
use
paradigm
male
femal
transplant
util
repeat
sequenc
chromosom
marker
harvey
et
al
oleari
blakemor
use
graftspecif
marker
make
use
genet
mismatch
graft
host
could
potenti
induc
immun
respons
engraft
cell
shown
two
commonli
use
marker
transplant
tissu
lac
z
abina
et
al
enhanc
green
fluoresc
protein
egfp
stripeck
et
al
rosenzweig
et
al
andersson
et
al
inher
marker
chromosom
probabl
appropri
sinc
although
hy
defin
alloantigen
simpson
et
al
studi
involv
engraft
male
glial
cell
demyelin
lesion
strain
femal
rat
result
surviv
male
cell
one
year
postengraft
oleari
blakemor
therefor
transplant
paradigm
appear
suitabl
evalu
longterm
surviv
allograft
make
demyelin
lesion
transplant
cell
tissu
inher
remyelin
capac
abolish
repres
altern
strategi
use
marker
identif
transplant
cell
situat
achiev
induc
demyelin
lesion
tissu
expos
gy
xirradi
blakemor
patterson
exposur
rat
spinal
cord
dose
xirradi
inhibit
remyelin
deplet
tissu
endogen
opc
popul
hink
et
al
valid
model
establish
number
mean
firstli
lack
remyelin
demyelin
lesion
anim
kill
two
month
postirradi
secondli
remyelin
seen
follow
transplant
promyelin
cell
natur
remyelin
relat
type
cell
introduc
transplant
opc
prepar
result
mainli
oligodendrocyt
remyelin
lesion
transplant
schwann
cell
result
schwann
cell
remyelin
thirdli
remyelin
xenograft
achiev
anim
immunosuppress
smith
blakemor
fourthli
xirradi
cm
spinal
cord
center
lesion
guarante
absenc
opc
lesion
even
two
month
lesion
induct
sinc
shown
endogen
opc
repopul
opcdeplet
tissu
rate
mm
per
week
month
old
anim
chari
et
al
thu
area
demyelin
situat
centr
cm
length
xirradi
tissu
endogen
opc
nonirradi
tissu
abl
reach
lesion
site
contribut
remyelin
least
four
month
main
advantag
xirradi
gliotoxin
model
allow
evalu
graft
surviv
simpli
examin
extent
remyelin
within
lesion
engraft
howev
possibl
disadvantag
approach
could
induct
bbb
dysfunct
li
et
al
effect
result
trigger
endotheli
cell
apoptosi
result
decreas
endotheli
cell
densiti
first
week
irradi
howev
day
postirradi
bbb
integr
restor
li
et
al
sinc
transplant
experi
involv
focal
induct
demyelin
gliotoxin
inject
bbb
disrupt
twice
first
lesion
induct
second
transplant
induct
temporari
bbb
dysfunct
first
week
two
week
follow
xirradi
may
compromis
variabl
anoth
effect
dose
xirradi
requir
inhibit
endogen
remyelin
induct
white
matter
necrosi
longer
surviv
time
stewart
et
al
analys
effect
exposur
rat
cervic
spinal
cord
gy
xirradi
notic
major
structur
chang
day
exposur
previou
studi
laboratori
use
gy
sign
tissu
necrosi
first
seen
three
month
postirradi
xeb
model
appear
suitabl
address
allograft
surviv
day
side
effect
xirradi
dose
requir
inhibit
remyelin
appear
enhanc
immun
respons
irradi
tissu
thu
love
et
al
found
local
exposur
spinal
cord
gy
xirradi
one
month
eae
induct
month
theiler
viru
inocul
result
local
exacerb
diseas
due
viral
reactiv
rais
possibl
cell
may
suscept
reject
irradi
tissu
normal
tissu
studi
use
model
could
overestim
immunogen
allograft
mhc
dispar
lead
caus
allograft
reject
roitt
parham
thu
consid
graft
cnsderiv
progenitor
replac
therapi
one
consid
mhc
express
time
engraft
establish
tissu
major
histocompat
complex
molecul
express
central
nervou
system
constitut
cell
cn
display
littl
express
mhc
antigen
lampson
hickey
vass
lassmann
muck
oldston
low
express
mhc
antigen
believ
import
factor
contribut
immuneprivileg
statu
cn
sinc
cell
lack
mhc
molecul
unabl
interact
immunocompet
cell
lampson
howev
mhc
mhc
ii
antigen
express
upregul
within
cn
consequ
inflamm
traugott
et
al
infect
olsson
et
al
potent
induc
mhc
express
ifng
produc
activ
cell
nk
cell
linda
et
al
differ
cell
type
within
cn
differ
degre
constitut
mhc
antigen
express
well
potenti
mhc
upregul
respons
cytokin
neural
stemprogenitor
cell
constitut
neural
stemprogenitor
cell
show
either
absenc
mhc
express
low
level
mhc
express
bailey
et
al
mclaren
et
al
drukker
et
al
express
upregul
ifng
treatment
mclaren
et
al
drukker
et
al
cell
differenti
mhc
express
reflect
natur
differenti
highest
level
mhc
express
observ
cell
differenti
astrocyt
mclaren
et
al
neuron
oligodendrocyt
popul
maintain
low
level
mhc
express
ii
microglia
cultur
microgli
cell
express
mhc
mhc
ii
howev
treatment
ifng
result
upregul
mhc
ii
antigen
frei
et
al
suzumura
et
al
induct
mhc
ii
antigen
express
microglia
also
shown
vivo
tissu
engraft
brain
finsen
et
al
retina
graft
cn
perri
lund
ischaem
kainic
acid
lesion
adult
hippocampu
finsen
et
al
presenc
mhc
ii
antigen
microglia
also
shown
lesion
acut
eae
vass
et
al
alzheim
diseas
dickson
et
al
ms
gobin
et
al
well
mous
model
parkinson
diseas
kurkowskajastrzebska
et
al
shown
mhc
ii
express
microgli
cell
increas
age
nonhuman
primat
sheffield
berman
normal
rat
brain
ogura
et
al
indic
increas
microgli
activ
age
interestingli
microglia
rat
brain
upregul
mhc
ii
express
high
dose
lipopolysaccharid
lp
buttini
et
al
ifng
steinig
van
der
meid
inject
intraven
suggest
peripher
immun
challeng
lead
microgli
activ
vass
lassmann
found
region
differ
number
mhc
ii
express
microgli
cell
highest
densiti
found
lumbar
spinal
cord
cerebellar
white
matter
lowest
densiti
forebrain
area
highest
constitut
microgli
mhc
ii
express
correspond
preferenti
site
inflammatori
infiltr
found
eae
levin
iii
astrocyt
vitro
astrocyt
constitut
express
mhc
satoh
et
al
massa
et
al
fontana
et
al
detect
mhc
ii
express
astrocyt
show
cell
abl
present
antigen
cell
specif
manner
restrict
mhc
later
studi
frei
et
al
howev
show
astrocyt
complet
immunoneg
mhc
ii
normal
state
signal
cell
probabl
mediat
ifng
induc
mhc
ii
express
studi
confirm
treatment
ifng
wong
et
al
lee
et
al
satoh
et
al
well
combin
ifng
tnfa
nikcevich
et
al
induc
express
mhc
ii
cell
vitro
massa
cowork
demonstr
hyperinduct
mhc
class
ii
molecul
astrocyt
vitro
strain
depend
thu
astrocyt
lewi
rat
highli
suscept
eae
express
much
higher
level
mhc
ii
molecul
astrocyt
deriv
eaeresist
strain
brown
norway
rat
shown
mous
eaesuscept
strain
sjl
compar
eaeresist
strain
balbc
massa
et
al
vivo
express
mhc
ii
antigen
matter
controversi
even
though
intrathec
applic
ifng
induc
mhc
ii
express
astrocyt
immunostain
weak
patchi
occur
later
less
intens
microglia
vass
lassmann
rat
hippocamp
primordia
mhc
class
ii
incompat
donor
graft
hippocampu
adult
rat
mhc
ii
upregul
astrocyt
observ
lawrenc
et
al
document
class
ii
posit
astrocyt
diseas
eae
ms
conflict
hickey
et
al
hofman
et
al
matsumoto
et
al
lee
et
al
sever
studi
found
mhc
ii
immunoposit
astrocyt
brain
ms
patient
hofman
et
al
traugott
zeinstra
et
al
normal
white
matter
mhc
ii
posit
astrocyt
found
traugott
zeinstra
et
al
howev
anoth
studi
gobin
et
al
astrocyt
ms
lesion
found
express
transcript
factor
control
figur
mhc
ii
express
neonat
rat
mix
glial
prepar
one
two
week
cultur
constitut
express
detect
upon
ifng
stimul
overnight
microgli
cell
readili
upregul
mhc
ii
express
low
level
express
detect
astrocyt
mhc
ii
express
detect
oligodendrocyt
oligodendrocyt
progenitor
even
cell
expos
high
concentr
ifng
scale
bar
mm
mhc
express
weakli
correspond
weak
mhc
mhc
ii
immunoreact
studi
mhc
ii
express
restrict
microglia
iv
oligodendrocyt
oligodendrocyt
show
low
level
surfac
mhc
class
molecul
cultur
wong
et
al
wong
et
al
massa
et
al
presenc
mhc
express
oligodendrocyt
shown
brain
patient
progress
multifoc
leukoencephalopathi
achim
wiley
well
oligodendrocyt
isol
corona
virusinfect
mous
brain
suzumura
et
al
treatment
oligodendrocyt
ifng
wong
et
al
satoh
et
al
massa
et
al
tnfa
mauerhoff
et
al
interleukin
il
suzumura
et
al
induc
increas
surfac
mhc
level
secret
factor
cell
also
induc
mhc
express
cultur
oligodendrocyt
suzumura
silberberg
oligodendrocyt
express
mhc
class
ii
molecul
cultur
duboi
et
al
satoh
et
al
vivo
grenier
et
al
mhc
ii
mrna
product
immunoreact
oligodendrocyt
induc
ifng
rat
optic
nerv
cultur
happen
exclus
presenc
glucocorticoid
dexamethason
bergsteindottir
et
al
ifng
wong
et
al
suzumura
et
al
satoh
et
al
bergsteindottir
et
al
influenc
allograftmedi
remyelin
prepar
contain
astrocyt
microglia
immunogen
transplant
allograft
prepar
enrich
cell
oligodendrocyt
lineag
examin
compar
extent
transplantmedi
remyelin
xirradi
eb
model
demyelin
follow
transplant
fulli
mismatch
mix
glial
cell
cultur
follow
transplant
cultur
deplet
astrocyt
therefor
enrich
oligodendrocyt
precursor
transplant
syngen
mix
glial
cultur
led
excel
remyelin
figur
allograft
similar
prepar
follow
reject
respons
graftderiv
oligodendrocyt
figur
well
transplant
oligodendrocyt
precursor
figur
f
process
start
around
one
month
complet
two
month
transplant
reject
mix
glial
allograft
vari
differ
donorhost
strain
combin
pvg
graft
lewi
rat
elicit
reject
host
four
week
posttransplant
figur
lewi
graft
pvg
show
surviv
host
four
eight
week
posttransplant
test
effect
remov
astrocyt
graft
surviv
transplant
astrocytedeplet
opcenrich
prepar
use
pvg
lewi
combin
previou
experi
result
reject
found
deplet
astrocyt
significantli
improv
graft
surviv
allograft
mediat
remyelin
present
anim
two
month
posttransplant
figur
furthermor
lewi
rat
transplant
pvg
opcenrich
allograft
show
dth
respons
either
prepar
pvg
alloantigen
spleen
cell
suggest
lack
immun
respons
graft
even
though
surviv
prepar
opcenrich
pure
cell
microgli
cell
sinc
cell
type
show
highest
level
mhc
express
differ
glial
cell
type
well
studi
review
major
histocompat
complex
molecul
express
cn
would
suggest
certain
threshold
mhc
glial
allograft
express
determin
whether
reject
trigger
may
also
differ
mhc
express
main
caus
differ
surviv
mix
glial
cell
prepar
opcenrich
prepar
sinc
main
differ
two
popul
astrocyt
content
possibl
presenc
cell
type
may
introduc
import
minor
antigen
may
elicit
reject
respons
altern
astrocyt
presenc
may
also
alter
cytokin
environ
lesion
favour
reject
respons
sinc
cell
secret
varieti
proinflammatori
cytokin
review
benvenist
must
also
rememb
astrocyt
present
within
transplant
prepar
would
like
activ
process
cultur
prepar
transplant
therefor
surviv
glial
allograft
appear
depend
balanc
factor
like
occur
prepar
enrich
opc
transplant
sinc
appear
capabl
suffici
prime
host
even
case
donorhost
combin
like
result
graft
reject
longterm
surviv
transplant
allogen
oligodendrocyt
lineag
cell
remain
investig
experi
probabl
need
perform
differ
demyelin
lesion
model
limit
xirradi
eb
lesion
discuss
model
section
review
review
focus
aspect
immun
respons
cn
pertin
achiev
graftmedi
remyelin
demyelin
diseas
ms
howev
may
crucial
prevent
reject
engraft
tissu
order
achiev
repair
due
complex
pathophysiolog
diseas
follow
section
discuss
reject
mismatch
graft
may
actual
stimul
repair
demyelin
lesion
sinc
host
promyelin
cell
present
within
adjac
tissu
area
chronic
demyelin
diseas
ms
lesion
divid
two
categori
remyelin
remyelin
absent
restrict
narrow
rim
around
peripheri
demyelin
plaqu
lucchinetti
et
al
indic
cn
abil
remyelin
demyelin
lesion
diseas
process
fail
reason
one
explan
remyelin
failur
progress
diseas
opc
addit
oligodendrocyt
becom
target
immun
attack
ms
would
result
demyelin
lesion
deplet
opc
situat
opc
neighbour
nonaffect
tissu
would
recruit
area
demyelin
order
achiev
remyelin
base
studi
examin
rate
adult
opc
repopul
opcdeplet
tissu
rat
propos
slow
rate
happen
mm
per
week
rat
year
age
chari
et
al
foot
blakemor
larg
area
opcdeplet
demyelin
would
take
consider
time
recruit
opc
interact
demyelin
axon
mani
studi
shown
stimulatori
effect
inflamm
remyelin
review
franklin
bieber
et
al
therefor
delay
interact
opc
demyelin
axon
mean
cell
expos
condit
present
acut
demyelin
lesion
would
normal
provid
stimuli
requir
activ
gener
remyelin
oligodendrocyt
support
propos
come
studi
opc
introduc
area
chronic
demyelin
fail
remyelin
axon
unless
acut
inflammatori
respons
induc
foot
blakemor
ii
experi
show
extent
remyelin
reduc
tempor
mismatch
demyelin
interact
opc
demyelin
axon
iii
observ
opc
premyelin
oligodendrocyt
found
area
chronic
demyelin
ms
without
evid
remyelin
chang
et
al
chang
et
al
import
inflamm
remyelin
one
suggest
reject
engraft
cell
may
benefici
host
opcmedi
remyelin
sinc
would
provid
acut
inflammatori
stimulu
requir
effici
remyelin
inde
studi
xenogen
opc
transplant
demyelin
lesion
offer
support
proposit
experi
mous
opc
transplant
spontan
repair
demyelin
lesion
model
induc
rat
spinal
cord
immunosuppress
transplant
mous
opc
remyelin
demyelin
axon
remov
immunosuppress
remyelin
mous
cell
reject
result
effici
remyelin
host
cell
similar
result
obtain
laboratori
transplant
allogen
mix
glial
prepar
reject
transplant
spontan
repair
demyelin
lesion
model
unpublish
data
therefor
experi
would
suggest
tissu
match
opc
transplant
treatment
demyelin
diseas
ms
may
crucial
sinc
either
surviv
reject
cell
could
ultim
lead
remyelin
articl
discuss
need
tissu
match
glial
graft
order
achiev
remyelin
nonrepair
demyelin
lesion
present
ms
cn
character
highli
specif
regul
immun
respons
surviv
allogen
oligodendrocyt
lineag
cell
appear
enhanc
situat
favour
graft
reject
prepar
enrich
cell
oligodendrocyt
lineag
transplant
result
studi
describ
howev
first
step
consid
glial
allograft
potenti
clinic
applic
rememb
experi
perform
toxininduc
rather
immunemedi
model
demyelin
system
prime
cell
oligodendrocyt
lineag
next
step
therefor
must
determin
fate
allogen
opc
transplant
model
immun
reaction
ongo
occur
eae
also
need
determin
whether
surviv
opc
allograft
due
induct
activ
toler
prepar
anoth
immun
privileg
site
bodi
eye
well
establish
engraft
anterior
chamber
result
enhanc
surviv
comparison
engraft
peripheri
also
suppress
dth
respons
engraft
antigen
phenomenon
name
anterior
chamber
associ
immun
deviat
acaid
review
streilein
acaid
mediat
induct
regulatori
cell
spleen
streilein
niederkorn
review
streilein
similar
phenomenon
name
brain
associ
immun
deviat
suggest
case
ovalbumin
place
striatum
mice
regulatori
cell
respons
dth
suppress
present
cervic
lymph
node
rather
spleen
wenkel
et
al
would
consist
differ
antigen
drainag
eye
cn
experi
would
requir
establish
whether
allograft
surviv
cn
requir
induct
regulatori
cell
possibl
result
immun
deviat
